Outlook Therapeutics Inc

Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing ONS-5010 which is a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration which is in clinical stage. Outlook Therapeutics Inc., formerly known as Oncobiologics Inc., is based in Cranbury, United States.

Address Details

Address: 485 ROUTE 1 SOUTH BUILDING F SUITE 320

City: ISELIN

State: NJ

Country: USA

Zip Code: 08830